Safety and efficacy of pregabalin in children (4-16 years) with partial onset seizures

Seizures are abnormal electrical impulses in the brain. The signs and symptoms of seizures vary depending on the type of seizure a patient has. This study is looking at the use of pregabalin in conjunction with other medications in pediatric patients (4-16years) with epilepsy

Medication Under Study:

Full study title:
A double blind, placebo-controlled parallel-group, multicenter study of the efficacy and safety of pregabalin as adjunctive therapy in children 4-16 years of age with partial onset seizures

IRB Study ID:

Who may qualify:

Pediatric patients (4-16 years) with partial onset seizures

Who does not qualify:

Patients  with other seizure types or medical conditions

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-5012

For urgent patient care matters involving a current study patient, please call: 330-920-5774

Lead Principal Investigator:

Thomas Enlow, MD
Pediatric Neurologist

Bookmark and Share

iGrow iGrow
Sign up for our parent enewsletter
    Contact Us



    find a location
    Find a location Type the first 3-5 letters of a specialty, service or location:
    Or, view: a map, a list of all locations, locations by city or locations near me.
    find a doctor
    Find a doctor Type the first 3-5 letters of the name, location or specialty:
    Or, view a list of all doctors by name, location and specialty.